SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-019256
Filing Date
2016-05-12
Accepted
2016-05-12 16:51:59
Documents
3
Period of Report
2016-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdtx-8k_20160512.htm 8-K 30409
2 EX-99.1 EARNINGS RELEASE cdtx-ex991_56.htm EX-99.1 107587
3 GRAPHIC gyjma0diqbu1000001.jpg GRAPHIC 3578
  Complete submission text file 0001564590-16-019256.txt   144343
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 161644665
SIC: 2836 Biological Products, (No Diagnostic Substances)